(ShareCast News) - Science and technology development company Allied Minds reported a wider loss in 2015 in its annual report on Monday, which it blamed on an increase in its investment in research and development and the creation of four new businesses during the year. The FTSE 250 firm posted a ne
Read more(ShareCast News) - Allied Minds has launched a new subsidiary to develop potential cancer drugs from compounds developed by the New York University School of Medicine. Allied's joint venture with pharma group Bristol-Myers Squibb, Allied-Bristol Life Sciences, has set up the subsidiary, called ißeCa
Read more(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 140.79 points (0.91%) to 15,357.20 by mid-afternoon. Redrow was near the top of the fallers list despite posting a rise in first half pre-tax profit as revenue and completions grew. In the six months to
Read more(ShareCast News) - Allied Minds laid out 2015 as a year of investment, rather than cashflow, as it updated the market on Tuesday of its trading in the 12 months to 31 December 2015. The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37
Read more